{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T05:40:50Z","timestamp":1711431650520},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>INTRODU\u00c7\u00c3O: A talidomida \u00e9 um f\u00e1rmaco utilizado atualmente no tratamento do eritema nodoso hans\u00eanico no Brasil. M\u00c9TODOS: Estudo prospectivo para acompanhar a evolu\u00e7\u00e3o cl\u00ednica, registrar os eventos adversos e determinar as concentra\u00e7\u00f5es plasm\u00e1ticas de talidomida em dose di\u00e1ria de 100mg\/dia, em 20 pacientes com manifesta\u00e7\u00f5es cl\u00ednicas de eritema nodoso hans\u00eanico, divididos em dois grupos: ap\u00f3s ou em curso da poliquimioterapia para hansen\u00edase. RESULTADOS: N\u00e3o foram observadas diferen\u00e7as significativas nos grupos no decorrer do estudo, tanto na evolu\u00e7\u00e3o cl\u00ednica favor\u00e1vel dos pacientes, de 70% e 90%, quanto nos eventos adversos registrados que foram tontura e sonol\u00eancia. Os teores plasm\u00e1ticos de talidomida em D7 e D14 foram de 0,82\u00b10,4\u03bcg\/mL e 0,79\u00b10,3\u03bcg\/mL no grupo 1 e de 0,82\u00b10,4 e 1,55\u00b11,0 no grupo 2, respectivamente. CONCLUS\u00d5ES: Na amostra estudada, a poliquimioterapia n\u00e3o interferiu na evolu\u00e7\u00e3o cl\u00ednica, na incid\u00eancia dos efeitos adversos e nos n\u00edveis plasm\u00e1ticos de talidomida.<\/jats:p>","DOI":"10.1590\/s0037-86822010000200019","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T09:39:55Z","timestamp":1272533995000},"page":"201-204","source":"Crossref","is-referenced-by-count":0,"title":["Talidomida usada por pacientes com eritema nodoso hans\u00eanico"],"prefix":"10.1590","volume":"43","author":[{"given":"Maria do Socorro da Silva","family":"Valente","sequence":"first","affiliation":[{"name":"Universidade Federal do Par\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luiz Fernandes","family":"Vieira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1590\/S0037-86822003000300010","article-title":"Hansen\u00edase no Brasil","volume":"36","author":"Ara\u00fajo MG","year":"2003","journal-title":"Rev Soc Bras Med Trop","ISSN":"http:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-4362.1990.tb04841.x","article-title":"Reactions in leprosy: A study of 250 patients in a multidrug therapy project, Baroda District, Gujarat India","volume":"29","author":"Chopra NK","year":"1990","journal-title":"Int J Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0036-46651998000600005","article-title":"Reactional states in multibacillary Hansen disease patients during multidrug therapy","volume":"40","author":"Nery JA","journal-title":"Rev Inst Med Trop"},{"key":"ref4","first-page":"113","article-title":"Hansen\u00edase: aspectos cl\u00ednicos, imunol\u00f3gicos e terap\u00eauticos","volume":"74","author":"Foss NT","year":"1999","journal-title":"An Bras Dermatol","ISSN":"http:\/\/id.crossref.org\/issn\/0365-0596","issn-type":"print"},{"key":"ref5","first-page":"560","article-title":"Thalidomide in leprosy: study of 94 cases","volume":"58","author":"Parikh DA","year":"1986","journal-title":"Indian J Lepr","ISSN":"http:\/\/id.crossref.org\/issn\/0254-9395","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1286-4579(02)01645-3","article-title":"Thalidomide in the treatment of leprosy","volume":"4","author":"Teo SK","year":"2002","journal-title":"Microbes Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1359-6446(04)03307-0","article-title":"Thalidomide as a novel therapeutic agent: new uses for an old product","volume":"10","author":"Teo SK","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002280100320","article-title":"Clinical pharmacology of thalidomide","volume":"57","author":"Eriksson T","year":"2001","journal-title":"Eur J Clin Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0031-6970","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","volume":"192","author":"Haslett PAJ","year":"2005","journal-title":"J Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref10","first-page":"218","article-title":"Correlation between TNF, increase of plasma C-reative protein level and supression of T lymphocyte response to concavalin A during erythema nodosum leprosum","volume":"61","author":"Foss NT","year":"1993","journal-title":"Int J Lep"},{"key":"ref11","series-title":"Guia Para o Controle da Hansen\u00edase","year":"2002","edition":"3"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2005.72.518","article-title":"A randomized double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum","volume":"72","author":"Vilahermosa LG","year":"2005","journal-title":"Am J Trop Med Hyg","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5935\/0305-7518.19960026","article-title":"The management of erythema nodosum leprosum: current and future options","volume":"67","author":"Lockwood DN","year":"1996","journal-title":"Lepr Rev","ISSN":"http:\/\/id.crossref.org\/issn\/0305-7518","issn-type":"print"},{"key":"ref14","first-page":"25","article-title":"Lei n\u00ba 10.651, de 16 de abril de 2003: Disp\u00f5e sobre o controle do uso da talidomida","year":"2003","journal-title":"Di\u00e1rio Oficial da Uni\u00e3o"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0009-9120(95)00019-6","article-title":"Determination of Thalidomide by High Performance Liquid Chromatography: Methodological Strategy for Clinical Trials","volume":"28","author":"Lyon AW","year":"1995","journal-title":"Clin Biochem","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9120","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/oxfordjournals.aje.a114012","article-title":"Leprosy case detection rates by age, sex and polar type under leprosy control conditions","volume":"12","author":"Vries JL","year":"1985","journal-title":"Am J Epidemiol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9262","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/AAC.41.12.2797","article-title":"Single-Dose Pharmacokinetics of Thalidomide in Human Immunodeficiency Virus-Infected Patients","volume":"41","author":"Piscitelli SC","year":"1997","journal-title":"Antimicrob Agents Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/009127009903901108","article-title":"Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers","volume":"39","author":"Teo SK","year":"1999","journal-title":"J Clin Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0091-2700","issn-type":"print"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v43n2\/19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:59:03Z","timestamp":1711429143000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822010000200019&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0037-86822010000200019"],"URL":"https:\/\/doi.org\/10.1590\/s0037-86822010000200019","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}